Cardiac Organoid Differentiation
Cardiac Organoid Differentiation - Related Videos
03:52
Differentiation and Maturation of Human Embryonic Stem Cells into Neural Organoids
0 Views •
2025
In this video, a stepwise protocol for Human embryonic stem cells into neural organoids is demonstrated. The method involves inducing neuronal rosette formation, followed by controlled maturation and final culturing on a hydrophobic membrane to achieve fully developed neural organoids.
13:03
Epigenetic Regulation of Cardiac Differentiation of Embryonic Stem Cells and Tissues
0 Views •
Cited by 3 •
2016
A fine tuning regulation of gene transcription underlies embryonic cell fate decision. Herein, we describe chromatin immunoprecipitation assays used to investigate epigenetic regulation of both cardiac differentiation of stem cells and cardiac development of mouse embryos.
09:48
In Vitro Resident Memory CD8 T Cell Differentiation Using Epithelial Organoid-T Cell Co-culture System
0 Views •
2026
To study CD8 T cell differentiation and function in vitro, CD8 T cells can be isolated from the mouse to be co-cultured long-term with preformed infected murine vaginal epithelial organoids. Here, we describe this process and assess the acquisition of resident memory T cell markers upon co-culture.
04:16
Prostate Organoid Assay: A Matrix Gel Ring-based Ex Vivo Culture Technique to Study the Differentiation Capacity of Prostate Epithelial Cells
0 Views •
2023
In this video, we demonstrate the culturing of isolated mouse prostate epithelial cells using a matrix gel-ring based culture technique. This approach can provide complementary information about the differentiation capacity of prostate epithelial cells to form 3D glandular structures in response to genetic or pharmacological manipulation.
06:28
Aggregate Size Optimization in Microwells for Suspension-based Cardiac Differentiation of Human Pluripotent Stem Cells
0 Views •
Cited by 10 •
2016
Conventional methods to initiate suspension aggregate based cardiac differentiation of human pluripotent stems cells (hPSCs) are plagued with culture heterogeneity with respect to aggregate size and shape. Here, we describe a robust method for cardiac differentiation employing microwells to generate size-controlled hPSC aggregates cultured under cardiac-promoting conditions.
FAQs
The timing of Wnt pathway modulation is central because sequential activation and inhibition guide pluripotent stem cells through mesoderm and then cardiac progenitor stages. This staged progression mirrors key decisions in early heart development rather than treating differentiation as a single event. It therefore helps researchers examine how signaling order influences cardiac lineage specification.
Cell-cell interactions help cardiac organoids organize into structured tissues as cells influence one another during differentiation. This organization is important because developmental outcomes depend not only on pathway signals but also on relationships among neighboring cells. In developmental biology, this feature makes the model useful for studying tissue organization during early heart formation.
The presence of cardiomyocytes alongside other cardiac cell types gives researchers more than a single lineage readout. It allows them to consider how multiple populations contribute to heart formation and tissue maturation. In developmental biology, this supports analysis of lineage specification within an organized model and helps connect cell-type composition with developmental outcomes.
A basic workflow begins with pluripotent stem cells in controlled culture, followed by timed modulation of Wnt signaling. The cells pass through mesoderm and cardiac progenitor states as interactions support three-dimensional organization. Researchers can then use the resulting tissues to examine cardiac development and maturation.
Cardiac organoids can be used to evaluate treatment effects and cardiotoxicity, meaning harmful effects on cardiac tissue. Because the model includes cardiac cell types within an organized tissue context, it provides a platform for examining how compounds affect developing heart-like tissues. This application extends developmental studies from lineage decisions to experimentally observed tissue responses.
In congenital heart disease research, cardiac organoids provide a way to investigate abnormalities in heart formation and lineage specification. Their scalable format also supports testing of regenerative strategies. This combination connects developmental mechanisms with regenerative-strategy testing while keeping early cardiac development at the center of the experimental model.